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Endothelial cells (ECs) are widely used in research, both for fundamental vascular biology research and for
exploring strategies to create engineered vascularized tissues. Primary isolation often results in contamination
from fibroblasts and vascular smooth muscle cells that can potentially affect function, particularly during the
initial expansion period needed to establish the cell culture. In the current study, we explored the use of
microcarriers to selectively isolate ECs from the lumen of intact vessels to enhance the purity during the
isolation procedure. First, rat aortic explant culture was performed and after 2 weeks of culture, flow cytometry
revealed that only 60% of the expanded cell population was positive for the endothelial marker CD31. Then, we
employed a strategy to selectively isolate ECs and improve their purity by introducing microcarriers to the
lumen of intact aorta. After 10 days, microcarriers were carefully removed and placed in cell culture dishes and
at 15 days, a large near confluent layer of primary ECs populated the dish. Flow cytometry revealed that > 90%
of the expanded cells expressed CD31. Moreover, the cells were capable of forming tubule-like structures when
plated onto Matrigel, confirming their function also. The highly modular and transportable nature of micro-
carriers has significant potential for isolating ECs at high purity, with minimal contamination.
Introduction
Vascular endothelial cells (ECs) have critical rolesin many physiological and pathological processes
in vivo.1 Consequently, ECs are valuable cells for funda-
mental research in vitro. Furthermore, development of en-
gineered organs is hindered by the fact that passive oxygen
perfusion in standard culture is limited to around 100mm
depth.2 For the emerging cell therapy field to successfully
produce tissue-engineered grafts ex vivo, the grafts will need
to be adequately vascularized to ensure delivery of oxygen to
maintain viability, facilitate engraftment, and restore tissue
function when transplanted in vivo.3 Therefore, successful
cultivation of ECs is going to be crucial for the develop-
ment of engineered vascularized tissues that will be the next
generation of engineered grafts.
ECs have been isolated from a range of different species
and from anatomically heterogeneous locations, and cell types
commonly employed for studies include umbilical vein ECs,
umbilical artery ECs, aortic ECs, and microvascular ECs
(often from the dermis due to ease of accessibility)4 as well as
endothelial progenitor cells,5,6 all of which have properties
that can be exploited for vascular biology research.7,8
Several methods can be adopted to isolate ECs, in-
cluding enzymatic digestion, combined mincing and en-
zymatic digestion, and mechanical scraping or physical
detachment of ECs from the underlying basement mem-
brane.4 Enzymatic digestion using collagenase detaches
the EC sheet from the underlying basement membrane and
the resulting cell population displays high purity. It is the
classical method used for isolating human umbilical vein
ECs,9 but a major disadvantage is that proteolytic diges-
tion can potentially damage key transmembrane pro-
teins, as can the centrifugation and trituration required
to derive a single cell suspension. Combined mincing
and digestion brings inherent contamination problems as
mincing vascular tissue will result in a mixed population
of cells with potential contaminants being vascular smooth
muscle cells, fibroblasts, and pericytes, depending on the
vessel origin. Mechanical scraping of ECs from large
vessels, such as the aorta,10 or physical detachment in
microvasculature by perfusion with microcarriers in a
cold buffer11,12 can yield different endothelial populations
that are high purity but low yield. Furthermore, the extent
of damage caused by the physical abrasion or cold shock,
respectively, is not fully characterized. Finally, explant
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cultures can be performed that are particularly useful for
arterial EC isolation.
Artery walls consist of three layers: tunica adventitia,
tunica media, and tunica intima. ECs reside in the innermost
layer of the tunica intima where they are in direct contact
with the blood. In explant culture, blood vessel tissue is
dissected and placed endothelial side down, so that ECs in
contact with the culture dish can migrate out of the explant.
However, poor dissection techniques may introduce con-
taminating fibroblasts or vascular smooth muscle cells from
the outer layers of the vessel. Moreover, fibroblasts are
highly motile and are capable of migrating from the upper
layer as part of the outgrowth population, further affect-
ing the purity of the EC population.13
Microcarriers that support cell attachment and growth have
enormous potential for achieving scalable cell expansion that
is required to meet the clinical demand for cell therapies.14–16
In addition, given the highly modular and transportable nature
of these substrates for cell growth, microcarriers might enable
a suitable alternative methodology to be adopted for the high-
purity isolation of ECs. Indeed, early studies utilized micro-
carriers to isolate the microvascular endothelium using a
perfusion method with cold saline and ethylenediaminete-
traacetic acid (EDTA) to release ECs from the basement
membrane onto the microcarrier surfaces.11
In the current study, we demonstrate that primary iso-
lation of rat aortic outgrowth ECs using the explant culture
method is suboptimal for isolating ECs due to the high
level of contamination present. We then demonstrate that a
newly established method that entails introducing poly(e-
caprolactone) (PCL) microcarriers to the lumen of the
intact aorta can isolate populations of ECs at significantly
improved purity.
Materials and Methods
Animals
This study was approved by the Animal Care and Use
Committee of Dankook University. Four male Sprague
Dawley rats were used.
Materials
Polymer and solvents used for the microsphere prepara-
tion. PCL (Mw=80,000; Sigma-Aldrich), chloroform (Sigma-
Aldrich), poly(vinyl alcohol) (PVA; Sigma-Aldrich), and 70%
ethanol.
Reagents used for the primary culture. Hanks’ balanced
salt solution (HBSS; Gibco), penicillin (100U/mL)/strep-
tomycin (100mg/mL; Sigma-Aldrich), Vascular Cell Basal
Medium (ATCC, cat # PCS-100-030), Endothelial Cell
Growth Kit (ATCC, cat # PCS-100-041), Dulbecco’s
phosphate-buffered saline (DPBS; Gibco), 0.25% trypsin/
1mM EDTA (Gibco-BRL), dimethyl sulfoxide (DMSO;
Sigma-Aldrich), and Matrigel (BD Bioscience).
Tools used for dissecting vascular and cell seeding.
Large scissors, dissecting scissors, large forceps, dissec-
ting forceps, 200 mL yellow pipette tips (ø: 1049.23 –
1.39 mm/540.1 – 0.97 mm), 1000 mL blue pipette tips (ø:
731.23 – 1.19 mm/399.88 – 1.2 mm), and an insulin syringe.
Cell culture vessels. Thirty-five-millimeter dishes, 60-
mm dishes, and 15-mL falcon tubes.
Imaging devices. Dissecting microscope, Samsung dig-
ital camera, inverted microscope (Olympus), ZEISS M700
confocal laser-scanning microscope (CLSM), and scanning
electron microscope (SEM; Hitachi S-3000H).
Fabrication of PCL microspheres
The PCL was dissolved in chloroform within a vial at
10wt.% while stirring for 3 h. The mixture solution was
dropped within a water pool containing 1wt.% PVA while
stirring at 600 rpm at 4C. The ratio of the mixture solution
to the water bath was determined as 1:30. The mixture so-
lution became solid rapidly on dropping into the ice-cooled
bath, and after the solidification, the solution was further
stirred for an additional 6 h to harden the microspheres. The
hardened microspheres were washed with ice-cooled dis-
tilled water five times through filtration with CHM Ashless
Filter papers (weight: 85 g/m2, thickness: 180mm). The
obtained PCL microspheres were further freeze dried and
kept at 4C for further characterization and use.
Cell culture procedure
Segments of thoracic aortae (22–25mm) were excised
from four male Sprague Dawley rats (190–250 g) and im-
mediately placed in cold HBSS. This solution was utilized
throughout the entire tissue dissociation procedure. Clotted
blood and connective tissue were dissected from the outer
wall of the vessels under the 10· magnification dissection
microscope. Any remaining blood residues were removed
by flushing the lumen of the vessels with a small volume of
HBSS. Then, the vessel was immersed in the Vascular Cell
Basal Medium supplemented with the Endothelial Cell
Growth Kit.
Fifteen milligrams of microspheres was sterilized with
70% ethanol for 2 h and washed with the PBS solution three
times. The microspheres were prewetted in the culture me-
dium for 12 h. The prewetted microspheres were placed in
the vessel lumen and cultured for 10 days. Then, the mi-
crospheres were moved into a 35-mm dish and cultured for
further 10 days. On day 11, the cells were trypsinized and
transferred into 60-mm culture dishes and cultured contin-
uously for 5 days.
Cell morphology observation and proliferation assay
To confirm the attachment and the distribution of the cells
on the microspheres, the specimens were stained using Alexa
Fluor 546-conjugated Phalloidin. Briefly, the specimens were
rinsed with 1mL of 1· PBS and fixed with 4% paraformal-
dehyde for 15min at room temperature (RT), then permea-
bilized in 0.2% Triton X-100 in 1· PBS for 5min, and
blocked with 1% (w/v) BSA in 1· PBS for 30min to prevent
nonspecific protein binding. The specimens were incubated
with 20 nM Alexa Fluor 546-conjugated Phalloidin diluted
in 1· PBS for 30min at RT, washed with 1mL of 1· PBS
three times for 5min each at RT. The specimens were cov-
ered with a mounting medium. A fluorescence image was
obtained using an Olympus IX71 inverted microscope
equipped with a DP-72 digital camera.
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To quantify the proliferation of the cells, cell counting
was performed using the trypan blue exclusion test. Briefly,
a uniform suspension containing the cells was added to the
trypan blue dye by a 1:1 dilution. The number of viable cells
was obtained by counting the cells of four 1· 1mm2 squares
of a hemocytometer and averaging. The total cell number of
viable (unstained) cells was calculated directly as mean
values of viable cells. Each experiment was repeated three
times.
Characteristic analysis of the primary EC culture
The characteristics of the ECs were confirmed by tube
formation and immunofluorescence staining for the von
Willebrand factor (vWF). For tube formation assay, 50mL
of thawed Matrigel solution was coated onto each well of a
four-well sterile plate and incubated for 30min at 37C to
allow the Matrigel solution to form a gel. HUVECs were
seeded at a density of 2 · 104 cells onto Matrigel and grown
in the Vascular Cell Basal Medium with the EC Growth Kit
for 1 day.
For vWF immunofluorescence staining, 3 · 104 cells were
directly seeded in 12-well plates with coverglass. After 3
days, the medium was removed and the cells were fixed by
incubating each well with 1mL of 4% paraformaldehyde for
10min at RT. The PFA was aspirated and the wells were
washed once with 1mL of 1· PBS at RT. The 1· PBS was
discarded, the cells were incubated for 30min at RT in a
blocking buffer (1% bovine serum albumin in 1· PBS), and
permeabilization was achieved by incubation with 0.1%
Triton X-100 for 5min. The blocking buffer was removed
and the primary antibody vWF solution (1:200 dilution in
1· PBS, cat # ab6322; Abcam) was added. The mixture was
incubated in the dark for 60min at RT. The primary anti-
body solution was aspirated and the wells were washed with
1mL of 1· PBS three times for 5min each at RT. The
secondary antibody goat anti-rabbit Alexa Fluor 555 solu-
tion (1:150 dilution in 1· PBS, cat # A21428; Invitrogen)
was added and incubated for 30min at RT in the dark. The
cells were washed with 1mL of 1· PBS three times for
5min each at RT. For nuclei counterstaining, the wells were
incubated with 0.5mg/mL 4¢,6-diamidino-2-phenylindole
(DAPI; Sigma-Aldrich) for 5min at RT. The DAPI was
removed and the coverglass containing the cells was mounted
on the slide with two drops of mounting medium. The borders
of each slide were covered with nail polish to fix the cover-
glass to the slide. A fluorescence image was taken on the
ZEISS M700 CLSM.
Flow cytometry analysis
The cells were suspended in 1mL 1· PBS at *1· 106
cells/mL. To detect EC-surface antigens, a 100-mL of the cell
suspension was put into a flow cytometry tube, a primary
antibody against PECAM-1 (CD31; cat# sc-80913; Santa
Cruz Biotechnology, Inc.) was added into the tube at 1mg/mg
and incubated for 30min at 4C. The cells were washed with
2mL of 1· PBS and pelleted by centrifugation at 1500 rpm
for 5min at RT. The supernatant was discarded and the
cell pellet was resuspended with 100mL of 1· PBS. The
FIG. 1. Contamination in cultures of outgrowth endothelial cells (ECs) from vessel explant tissue. (A) Schematic rep-
resentation of the artery wall composed of three layers: the outer tunica adventitia, containing fibroblasts; tunica media,
contains vascular smooth muscle cells; and inner tunica intima, where the ECs reside. (B) Schematic of aortic segment
explant culture with the endothelial layer face down for 9 days. Also, depicted are the potential contaminating fibroblasts.
(C) Outgrowth cells from rat aortic tissue that were cultured additionally for 14 days to expand the cell population were only
59.6% – 11.6% (from triplicate experiments) positive for the EC marker CD31. FACS representative results are shown from
three different experimental sets. Color images available online at www.liebertpub.com/tec
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fluorescein isothiocynate-conjugated secondary antibody (cat#
sc2010; Santa Cruz Biotechnology, Inc.) at 1mg/mL was ad-
ded into the tube and incubated for 30min at 4C in the dark.
The cells were washed with 2mL of 1· PBS and pelleted by
centrifugation at 1500 rpm for 5min at RT. The supernatant
was discarded and the cell pellet was resuspended with 0.5mL
of 1· PBS. Labeled cells were analyzed by a flow cytometer
(FACS Calibur; Becton Dickinson) and Cell Quest software
(Becton Dickinson).
Statistical analysis
Data are shown as the mean – one standard deviation.
Statistical comparisons were made using the Student’s t-test.
p < 0.01 was considered to be statistically significant.
Results
Purity of expanded isolations of outgrowth
ECs from rat aortic tissue explants
To confirm that contamination from non-EC types from
the arterial wall (Fig. 1A, B) results from explant culture,
segments of rat aorta were placed lumen side down in cell
culture dishes and incubated for 9 days to enable cell
outgrowth. Cells were then cultured for further 14 days to
obtain an established culture of cells that could then be
assessed by flow cytometry. Flow cytometry using an
antibody to CD31 (PECAM) revealed that only 60% of
cells within the population were positive for the EC
marker (Fig. 1C).
Microcarrier scaffold characterization
The PCL microcarriers produced as described previously17
characterized using SEM to demonstrate their morphology
(Fig. 2A). They had a relatively broad size distribution (Fig.
2B) and those within the range 200–500mm (average diam-
eter= 386mm) were used for cell culture.
Microcarrier isolation of cells
Standard dissection tools were used to prepare thoracic
aortas (Fig. 3A) and the aortas typically had a length of
around 22–25mm (Fig. 3B). After loading the aortas with
FIG. 2. Poly(e-caprolactone) (PCL) mi-
crocarrier characteristics. (A) Scanning
electron microscopy micrograph depicting
PCL microcarrier appearance. (B) Size dis-
tribution of the microspheres. Average di-
ameter of the microspheres is 386mm. Scale
bar in (A) 500 mm.
FIG. 3. Equipment for the
preparation of microcarrier-
loaded aortic organ cultures.
(A) Tools used for dissecting
vascular tissue and dispens-
ing microcarriers. (B) Seg-
ment of thoracic aorta. (C)
Organotypic culture of aorta
filled with microcarriers in a
35-mm dish. (D) Cell isola-
tion on microcarriers re-
trieved using a yellow 200mL
pipette tip. Scale bars in (D)
200 mm. Color images avail-
able online at www
.liebertpub.com/tec
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microcarriers, they were maintained as organ cultures ex
vivo, (as illustrated in Fig. 3C). Retrieval of cells on mi-
crocarriers was accomplished using a yellow pipette tip
(Fig. 3D). The basic concept of utilizing microcarriers
placed in the lumen of an intact aorta as a strategy to im-
prove EC purity at isolation is presented in Figure 4. It was
expected that if microcarriers were introduced to the vessel
lumen through a pipette and tissue culture performed, cells
would migrate onto the microcarrier substrates and populate
them over time.
Cell morphology, growth, and phenotype
As predicted, a growing number of ECs migrated out of
the inner wall of the blood vessel onto the surface of the
scaffold over time (Fig. 5). After 5 days of culture, ECs
were observed on microcarriers, although relatively few
cells were present (Fig. 5A, B). However, after 10 days,
many more cells were present on microcarriers (Fig. 5C, D).
At this time, cells were then transferred to a 35-mm dish
and cultured. ECs started to migrate from the microcarriers
onto the plastic substrate of the culture dish from 2 days
postincubation (Fig. 6A–C), and the culture was maintained
for 10 days. The resulting cell population was then trans-
ferred to a 60-mm dish and cultured continuously for 5 days.
The cell population grew in size to form a monolayer with
cells displaying morphology typical of stromal cells and cell
counts indicated population growth (Fig. 6D–F).
The functional capacity and phenotype of the cells were
then assessed to determine whether the expanded cell pop-
ulation from microcarriers, cultured in the aorta lumen, was
indeed ECs that have appropriate functional characteristics.
FIG. 4. Schematic illustra-
tion of the multistep process
for the isolation of primary
culture of rat ECs using PCL
microcarriers. Color images
available online at www
.liebertpub.com/tec
FIG. 5. Immunofluorescent
labeling to characterize EC
attachment to PCL micro-
carriers. Cellularity after (A,
B) 5 days or (C, D) 10 days
of incubation of micro-
carriers in the aorta lumen.
Actin cytoskeletons were la-
beled with Alexafluor 546-
conjugated phalloidin (or-
ange). Scale bars in (A, C)
200mm; (B, D) 100mm.
Color images available on-
line at www.liebertpub
.com/tec
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FIG. 6. Phase-contrast micrograph images of primary aortic ECs migrating from microcarriers onto tissue culture plastic
over time at 0, 2, 6, and 9 days (A–D). (E, F) Monolayer of cells 5 days after passaging into a 60-mm dish. (G) Cell yield
obtained 10 days following transfer from microcarriers and expansion in 35-mm dishes, and subsequently, 5 days after
transfer to 60-mm dishes was recorded and expansion was achieved. Values =mean – SD. Scale bars in (A–D) 150mm; (E)
400 mm; (F) 100 mm. Statistical significance (**p < 0.01). Color images available online at www.liebertpub.com/tec
FIG. 7. Phenotypic char-
acterization of primary vas-
cular ECs. (A) ECs cultured
on Matrigel were capable of
forming tubule-like networks
typical of vascular cells. (B)
The population stained posi-
tive for the EC marker von
Willebrand factor (vWF)
(red = vWF, blue = 4¢,6-dia-
midino-2-phenylindole
[DAPI]). (C) Flow cytometry
demonstrated that 93% of the
population was positive for
CD31, compared with the
IgG control. Scale bars in (A)
150 mm; (B) 50 mm. Color
images available online at
www.liebertpub.com/tec
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A tubule formation assay performed on Matrigel demon-
strated that the cells, when placed in the appropriate bio-
chemical and biophysical environment, are capable of
forming tubule-like structures (Fig. 7A). Moreover, the cells
in culture were positive for the EC marker vWF (Fig. 7B),
indicating that the tubule-like network was not an artifact of
the vascular culture conditions on a non-EC type. Finally,
the cell population resulting from the overall culture period
was assessed for CD31 expression using flow cytometry to
determine the total proportion of cells within the population
that were truly ECs. Ninety-three percent of the resultant
population was positive for CD31, confirming the enhanced
purity, even after expansion, using the novel microcarrier-
based isolation method (Fig. 7C).
Discussion
Several methods have been routinely adopted for isolation
of ECs, including enzymatic digestion, mechanical/physical
methods, and outgrowth from explants.4 Each method has
advantages for isolating ECs from a variety of heteroge-
neously different target tissues; yet, each also brings its own
limitations, with high purity often coming at the expense of
yield or vice versa.
Outgrowth of ECs from tissue explants carries the risk of
contamination from non-EC types present in the tissue. For
example, it has been demonstrated that low-density lipoprotein
presented in one of the two modified forms can induce out-
growth of either ECs or smooth muscle cells, depending on its
state.18 Our initial characterization of outgrowth cells from rat
aortic tissue explants indicated that only 60% of the population
obtained after expansion for 5 days in vitro was positive for
the endothelial marker CD31. Therefore, we sought to assess
whether PCL microcarriers could be used to isolate ECs at
high purity from intact aortas under passive culture conditions.
We utilized PCL microcarriers because among the fre-
quently used biocompatible degradable polymers, such as PCL,
poly(lactic acid) (PLA), poly(glycolic acid) (PGA), and their
copolymers, PCL is the least degradable among them and,
hence, is thought to provide the most stable scaffold to support
cells without the concern of degradation-related issues during
cell isolation. However, it might be useful to study the com-
positional effects on cell isolation efficiency in the near future.
Due to the lumen diameter of the aortas (*1.33– 0.09mm),
we introduced large microcarriers of 200–500mm to the vessel
lumen and cultured under static conditions after prewetting
the aorta and the microcarriers. The result was migration of
ECs from the vessel lumen to the microcarrier surface and
there was an increase in microcarrier cellularity from day 5 to
10 of incubation. Early studies isolating the microvascular
endothelium with microcarriers utilized perfusion and cold
buffer containing EDTA to shock ECs mediating their de-
tachment from the basement membrane and attachment to the
microcarrier surface.11,12 The extent to which this will impact
on cell viability and phenotype, by selecting out a resistant
population is unclear, although a cell population resilient to
bioprocess forces is clearly attractive. However, our aim was to
increase the purity of the population using a passive method-
ology, and cell-loaded microcarriers were placed in 35-mm
tissue culture dishes, where cells readily migrated onto the
plastic and formed a monolayer by 10 days of culture. The
population could be expanded further still after passaging to a
60-mm dish, and the subsequent expanded population was
more than 90% positive for CD31, expressed vWF and
demonstrated functional capability to form tubule-like struc-
tures on Matrigel.
The method we have described may be suitable for
isolating ECs from smaller caliber vessels, using micro-
carriers of smaller diameter where necessary. This would
make the isolation amenable for isolating a range of to-
pographically distinct endothelial populations from dif-
ferent regions such as the arteries and veins, large-diameter
vessels versus small-diameter vessels. Subsequent research
will focus on applying the methodology for isolating ECs
from different types of vessels assessing the impact of
microcarrier size.
In conclusion, we demonstrated the proof of concept that
PCL microcarriers could be used as a passive means of high-
purity isolation of ECs from intact aortas.
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